• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pseudomonas aeruginosa bloodstream infection in patients with hematological diseases: Clinical outcomes and prediction model of multidrug-resistant infections.

作者信息

Zhao Yuanqi, Lin Qingsong, Zhang Tingting, Zhen Sisi, Wang Jieru, Jiang Erlie, Mi Yingchang, Qiu Lugui, Han Mingzhe, Wang Jianxiang, Feng Sizhou

机构信息

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China; Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital, Fuzhou, China.

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.

出版信息

J Infect. 2023 Jan;86(1):66-117. doi: 10.1016/j.jinf.2022.08.037. Epub 2022 Sep 3.

DOI:10.1016/j.jinf.2022.08.037
PMID:36064048
Abstract
摘要

相似文献

1
Pseudomonas aeruginosa bloodstream infection in patients with hematological diseases: Clinical outcomes and prediction model of multidrug-resistant infections.血液系统疾病患者的铜绿假单胞菌血流感染：多重耐药感染的临床结局及预测模型
J Infect. 2023 Jan;86(1):66-117. doi: 10.1016/j.jinf.2022.08.037. Epub 2022 Sep 3.
2
Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study).中性粒细胞减少症血液病患者铜绿假单胞菌血流感染的真实世界应用头孢他啶/他唑巴坦治疗：一项匹配对照研究（ZENITH 研究）。
Microbiol Spectr. 2022 Jun 29;10(3):e0229221. doi: 10.1128/spectrum.02292-21. Epub 2022 Apr 27.
3
Clinical outcomes, molecular epidemiology and resistance mechanisms of multidrug-resistant isolated from bloodstream infections from Qatar.从卡塔尔血流感染中分离的多药耐药菌的临床结果、分子流行病学和耐药机制。
Ann Med. 2021 Dec;53(1):2345-2353. doi: 10.1080/07853890.2021.2012588.
4
Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant in patients with hematological diseases.血液病患者碳青霉烯类耐药菌血流感染的死亡相关危险因素评估及有效抗菌治疗方案。
Front Cell Infect Microbiol. 2023 Jun 21;13:1156651. doi: 10.3389/fcimb.2023.1156651. eCollection 2023.
5
Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa.中性粒细胞减少癌症患者血流感染铜绿假单胞菌所致多药耐药的临床预测模型。
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.02494-19.
6
[Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].[铜绿假单胞菌血症：与感染源及抗生素耐药性的关联]
Medicina (Kaunas). 2009;45(1):1-7.
7
Co-harboring of mcr-1 and β-lactamase genes in Pseudomonas aeruginosa by high-resolution melting curve analysis (HRMA): Molecular typing of superbug strains in bloodstream infections (BSI).高产碳青霉烯酶基因 mcr-1 与铜绿假单胞菌β-内酰胺酶基因的共同携带：血流感染（BSI）中超级细菌株的分子分型。
Infect Genet Evol. 2020 Nov;85:104518. doi: 10.1016/j.meegid.2020.104518. Epub 2020 Sep 4.
8
Monobactam and aminoglycoside combination therapy against metallo-beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa screened using a 'break-point checkerboard plate'.使用“断点棋盘平板”筛选针对产金属β-内酰胺酶的多重耐药铜绿假单胞菌的单环β-内酰胺类与氨基糖苷类联合治疗
Scand J Infect Dis. 2010 Mar;42(3):231-3. doi: 10.3109/00365540903443157.
9
The peculiarities of Pseudomonas aeruginosa resistance to antibiotics and prevalence of serogroups.铜绿假单胞菌对抗生素的耐药特性及血清型分布情况
Medicina (Kaunas). 2007;43(1):36-42.
10
Successful treatment of multidrug-resistant Pseudomonas aeruginosa breakthrough bacteremia with ceftolozane/tazobactam.用头孢他啶/他唑巴坦成功治疗多重耐药铜绿假单胞菌突破性菌血症。
Infection. 2017 Feb;45(1):115-117. doi: 10.1007/s15010-016-0944-5. Epub 2016 Sep 26.

引用本文的文献

1
Molecular Basis for the Activation of MsbA by Divalent Metals.二价金属激活MsbA的分子基础。
J Am Chem Soc. 2025 Sep 3;147(35):31488-31496. doi: 10.1021/jacs.4c18759. Epub 2025 Aug 25.
2
Antibiotic stewardship in hematological patients with Escherichia coli and Klebsiella pneumoniae bloodstream infections: evaluating short-course and carbapenem-sparing strategies.血液系统疾病患者大肠埃希菌和肺炎克雷伯菌血流感染的抗生素管理：评估短疗程和碳青霉烯类药物节省策略。
Ann Clin Microbiol Antimicrob. 2025 May 29;24(1):34. doi: 10.1186/s12941-025-00801-y.
3
enhances anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8 T cells.
通过激活细胞毒性CD8 T细胞增强抗PD-1在结直肠癌中的疗效。
Front Immunol. 2025 Mar 21;16:1553757. doi: 10.3389/fimmu.2025.1553757. eCollection 2025.
4
Machine learning-based prognostic model for bloodstream infections in hematological malignancies using Th1/Th2 cytokines.基于机器学习的使用Th1/Th2细胞因子的血液系统恶性肿瘤血流感染预后模型。
BMC Infect Dis. 2025 Mar 26;25(1):415. doi: 10.1186/s12879-025-10808-7.
5
Clinical Characteristics and Optimization of Empirical Antimicrobial Therapy for Febrile Neutropenia in Patients With Hematologic Malignancies.血液系统恶性肿瘤患者发热性中性粒细胞减少症的临床特征及经验性抗菌治疗的优化
Infect Drug Resist. 2025 Feb 7;18:715-729. doi: 10.2147/IDR.S493670. eCollection 2025.
6
Multicenter Surveillance of Isolates From Blood: Clinical Distribution Characteristics and Antibiotic Resistance Trends in Hebei Province, China (2016-2021).中国河北省血液分离株的多中心监测：临床分布特征及抗生素耐药趋势（2016 - 2021年）
Infect Drug Resist. 2025 Feb 5;18:703-713. doi: 10.2147/IDR.S489527. eCollection 2025.
7
[Clinical features and prognosis of Pseudomonas aeruginosa infection in patients with hematologic malignancies].[血液系统恶性肿瘤患者铜绿假单胞菌感染的临床特征与预后]
Zhonghua Xue Ye Xue Za Zhi. 2024 Nov 14;45(11):1028-1034. doi: 10.3760/cma.j.cn121090-20240824-00319.
8
Development and validation a nomogram prediction model for early diagnosis of bloodstream infections in the intensive care unit.开发和验证 ICU 血流感染早期诊断的列线图预测模型。
Front Cell Infect Microbiol. 2024 Mar 4;14:1348896. doi: 10.3389/fcimb.2024.1348896. eCollection 2024.
9
Microbiology and prognostic prediction model of bloodstream infection in patients with hematological malignancies.血液病恶性肿瘤患者血流感染的微生物学及预后预测模型。
Front Cell Infect Microbiol. 2023 Jun 30;13:1167638. doi: 10.3389/fcimb.2023.1167638. eCollection 2023.
10
Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant in patients with hematological diseases.血液病患者碳青霉烯类耐药菌血流感染的死亡相关危险因素评估及有效抗菌治疗方案。
Front Cell Infect Microbiol. 2023 Jun 21;13:1156651. doi: 10.3389/fcimb.2023.1156651. eCollection 2023.